CLINICAL_TRIALS
trial_result
· 2016-10-13
Clinical Trial Update: LIPS-A: Lung Injury Prevention Study With Aspirin [Phase 2]
Summary
The Phase 2 LIPS-A trial evaluating aspirin to prevent lung injury in acute respiratory distress syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-10-13